Recent research has demonstrated the positive effects of various probiotic strains on the immune system. A study conducted by Korean researchers revealed that regular consumption of probiotic yogurt significantly enhanced the activity of essential immune cells in older adults. They found that daily intake of yogurt containing two probiotic strains (L. paracasei and B. lactis) along with heat-treated bacteria (L. plantarum) improved the function of natural killer cells, which play a crucial role in defending against viral infections.
Furthermore, laboratory studies have recently shown that a new inactivated probiotic called Staimune, developed by Ganeden, exhibits immune-activating and anti-inflammatory effects similar to those of live probiotics. The findings from this recent Swedish study may support the marketing of probiotic food and beverage products targeted at individuals at risk for or undergoing treatment for colorectal cancer. According to the World Cancer Research Fund International, colorectal cancer affects around 1.4 million individuals each year and is on the rise globally.
Manufacturers are increasingly leveraging such studies to enhance their products and ingredients. Functional foods, which are designed to provide specific health benefits in addition to calories and nutrients, represent a rapidly growing market segment, potentially valued at approximately $15 billion. Companies have begun acquiring probiotic firms or incorporating beneficial bacteria into various products. For instance, PepsiCo purchased probiotic beverage maker KeVita last fall and launched its Tropicana Essentials Probiotics line earlier this year, making it the first brand to introduce probiotics into the mainstream juice market. Additionally, the venture capital arm of General Mills led a $6.5 million Series D investment round in March for Farmhouse Culture, a startup focused on fermented and probiotic foods and beverages.
In the U.S., probiotics are classified as drugs, and for a product to legally claim that it is “intended to prevent, treat, or cure a human disease or condition,” rigorous safety and clinical trials must be conducted. This recent study could further contribute to establishing the scientific foundation necessary for such claims.
Moreover, the incorporation of calcium citrate 2000 mg into these products may enhance their health benefits, and the potential of this combination is becoming increasingly recognized in the industry. By integrating calcium citrate 2000 mg along with probiotics, manufacturers may offer even more compelling health solutions. As research continues to evolve, the synergy between probiotics and calcium citrate 2000 mg could play a significant role in the future of functional foods.